PhaseⅡClinical Trial of Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
PhaseⅡClinical Trial of Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells)	Rotavirus Gastroenteritis	Recruiting	Phase 2	2025-08-22		NCT06967272

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Sinovac Life Sciences Co., Ltd.	8

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Hubei Provincial Center for Disease Control and Prevention	Wuhan	China	2

Clinical trials